# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Goldman Sachs analyst Matthew Sykes maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $88 t...
Evercore ISI Group analyst Vijay Kumar maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and lowers the price target ...
BTIG analyst Mark Massaro maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $80 to $70.
Scotiabank analyst Sung Ji Nam initiates coverage on Exact Sciences (NASDAQ:EXAS) with a Sector Outperform rating and announ...
BTIG analyst Mark Massaro maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $80 to $70.